The 2nd NIKKEI Drug Discovery Ecosystem Summit

Fumio Kishida

Former Prime Minister of Japan
Member of the House of Representatives

Kenichiro Ueno

Minister of Health, Labour and Welfare
Member of the House of Representatives

Hideki Murai

Former Deputy Chief Cabinet Secretary
Member of the House of Representatives

Akihisa Shiozaki

Former Parliamentary Secretary for Health, Labour and Welfare
Member of the House of Representatives

Gaku Hashimoto

Former State Ministers of Health, Labour and Welfare
Member of the House of Representatives

Yasushi Katsume

Member of the House of Representative

Sawori Imura

Senior Director, Product Supply, PGS Japan Lead, Pfizer Japan Inc. /
President & Representative Director,Pfizer Global Supply Japan Inc.

Yasuhiro Watabe

Life Sciences Industry Lead, Anthropic Japan

John Paul Pullicino

Chair
European Federation of Pharmaceutical Industries and Associations Japan (EFPIA Japan)
President & Representative Director
Novartis Pharma K.K.

Ryoji Noritake

Chair, Health and Global Policy Institute

Hiroyuki Uchiyama

Director-General, National Healthcare Policy Secretariat
Cabinet Office, Government of Japan

Hiroya Hirose

Director, Bio-Industry Division, Commerce and Service Industry Policy Group
Ministry of Economy, Trade and Industry

Osamu Okuda

Vice Chairman, Japan Pharmaceutical Manufacturers Association

Ken-ichiro Hata

D.D.S., Ph.D.
Repewsentative Director, Chairperson
Forum for Innovative Regenerative Medicine

Toshio Fujimoto

CEO, iPark Institute Co., Ltd.

Mayu Yoshikawa

Ph.D.
Venture Partner, ARCH Venture Partners

Kotaro Funato

Health Industries Advisory / Managing Director
PwC Consulting LLC

Kiyoshi Ando

Senior Staff Writer, Nikkei Inc.

Kenji Yasukawa

Ph.D., Representative Director, Chairman of the Board, Astellas Pharma. Inc. ／ President, The Federation of Pharmaceutical Manufacturers' Associations of JAPAN

Sunao Manabe

Senior Advisor, Daiichi Sankyo Co., Ltd.

Yukiko Sakakibara

Head, Business Strategy, Japan Pharmaceutical Manufacturers Association ／
Head, Market Access & Public Affairs, Japan Pharma Business Unit, Takeda Pharmaceutical Co., Ltd.

Marc Dunoyer

Chief Strategy Officer, AstraZeneca PLC

Noriko Hattori

VP, Corporate Affairs & Strategy, AstraZeneca K.K.

Takeshi Annaka

Director, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management
Health Policy Bureau, Ministry of Health, Labour and Welfare

Ataru Igarashi

Professor
Graduate School of Business Administration, Keio University

Shinsuke Amano

Representative Director
Japan Federation of Cancer Patient Groups

Masanobu Saito

Head of Value & Access, Novartis Pharma K.K.

Akira Kanehisa

Head of Clinical Development, Site Development Head・Executive Director, Gilead Sciences, Inc.

Shintaro Sengoku

Professor, School of Environment and Society, Institute of Science Tokyo

Katsunobu Kato

Member of The House of Representatives

Takanori Teshima

MD., Ph.D, Professor, Department of Hematology, Hokkaido University Faculty of Medicine

Kazuhito Ihara

Vice-Minister of Health, Labour and Welfare, Ministry of Health, Labour and Welfare

Hiroyuki Kawabata

Deputy Japan Representative, PhRMA

Andrew Hexter

President and Representative Director, Gilead Sciences K.K.

Toshihiko Takeda

Senior Advisor, Boston Consulting Group

Naomi Tokashiki

Member of the House of Representatives

Yasuhiro Suzuki

President, International University of Health and Welfare

Minoru Akiyama

Director, National Federation of Health Insurance Societies (Kenporen)

Kazuyo Tsushita

Professor, Japan Nutrition University

Satoshi Takeuchi

Director, Health Promotion Division, Health and Welfare Affairs Bureau, Hiroshima Prefecture

Ryo Kato

Director, Market Access and External Affairs, Novo Nordisk Pharma Ltd.

Hirokazu Shimoda

Japan Agency for Medical Research and Development

Yoshiki Sawa

CEO President, Organization of Future Medicine
President, Osaka Keisatsu Hospital
Emeritus Professor, Osaka University

Wataru Akahata

Ph.D., Founder and CEO, VLP Therapeutics, Inc.
Founder, CEO, and Chief R&D Officer, VLP Therapeutics Japan, Inc.

Shinichiro Komoto

Partner, Eight Roads Ventures Japan

Hiroo Igarashi

Chairperson
Japan Executive Committee, Pharmaceutical Research and Manufacturers of America (PhRMA)

Emil Kongshøj Larsen

Executive Vice President
International Operations, Novo Nordisk

Hitoshi Iikura

Ph.D., Director, Executive Vice President
Chugai Pharmaceutical Co., Ltd.

Masahiro Mori

Assistant Minister for Pharmaceutical Industry Promotion & Healthcare DX, Ministry of Health, Labour & Welfare (MHLW)

Christopher Rieger

President & Representative Director, Johnson＆Johnson Innovative Medicine Japan

Nathan Walters

VP, therapeutic area market access lead, oncology, Johnson＆Johnson Innovative Medicine

Hiroaki Tsukada

Senior Director, Head of Government Affairs and Policy, Japan & Asia Pacific, Johnson＆Johnson Innovative Medicine Japan

Kanae Kurata

Director, Life Sciences Division, Research Promotion Bureau
Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Tomohiro Anzai

Managing Partner, Fast Track Initiative, Inc.

Akihiko Soyama

Executive Producer and General Ambassador, MEDISO

Yasuhiro Fujiwara

M.D., Ph.D.
Chief Executive
Pharmaceuticals and Medical Devices Agency

Takashi Kaminagayoshi

Head of Biotherapeutic Process Development Japan, Pharmaceutical Sciences, R&D
Takeda Pharmaceutical Co., Ltd.

Kai Nishimura

President/Chief Executive Officer Publisher
Nikkei Science Inc.

Hide Goto

Ph.D., Head, Open Innovation Management / Vice President, Astellas Pharma. Inc.

Takao Suzuki

Head of Digital Transformation Unit, Associate Vice President, Chugai Pharmaceutical Co., Ltd.

Yukako Hinohara

Counsellor
National Healthcare Policy Secretariat, Cabinet Office

Hideaki Hanaki

Project Professor
The Ōmura Satoshi Memorial Institute, Kitasato University/
Project Professor, Flotilla Ōmura Memorial Research Organization of Microbial Natural Resources

Mitsuhiko Ida

Head of Policy, Communications and Community Engagement, Pfizer Japan Inc.

Tamayo Marukawa

Member of the House of Representatives

Tomoyoshi　Koyanagi

Director of Business Development, Program-Specific Professor, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital

Yoshitsugu Shitaka

President & CEO, RealizeEdge Partners

Jun Kusunoki

External Scientific Innovation Asia Pacific, Senior Director, Japan Country Lead, Johnson & Johnson

Yoshinori Ikeura

Representative Director, President＆CEO, Axcelead, Inc.

Yasuko Terao

Chairperson, Innovation Promotion Subcommittee, Japan Pharmaceutical Manufacturers Association